Keyphrases
Caffeine
33%
Citalopram
100%
Clinical Prediction Model
11%
CYP2C19
100%
Cytochrome P450 1A2 (CYP1A2)
100%
Cytochrome P450 2D6 (CYP2D6)
100%
Demethylation
11%
Dose Effect
100%
Extensive Metabolizer
33%
Fluoxetine
100%
Fluvoxamine
100%
Healthy Young
11%
Increased Dose
22%
Limit of Quantification
11%
Long Half-life
11%
Mephenytoin
44%
Metabolic Ratio
22%
Multiple Dose
11%
Norfluoxetine
11%
Page Test
22%
Paroxetine
100%
Pharmacokinetic Study
11%
Poor Metabolizer
33%
Potent Inhibitor
22%
R-ratio
11%
Selective Serotonin Reuptake Inhibitors
44%
Single Oral Dose
11%
Single-dose Studies
11%
Sparteine
33%
Steady State
11%
Testing Trends
22%
Urinary Excretion
11%
Pharmacology, Toxicology and Pharmaceutical Science
Citalopram
100%
CYP1A2
100%
CYP2C19
100%
CYP2D6
100%
Fluoxetine
100%
Fluvoxamine
100%
Mephenytoin
44%
Paroxetine
100%
Pharmacokinetics
11%
Selective Serotonin Reuptake Inhibitor
44%
Seproxetine
11%
Sparteine
33%